Fingerprint
Dive into the research topics of 'AML-351 Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
AML-351 Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies
Lauren Shapiro, Ioannis Mantzaris, Aditi Shastri, Alejandro Sica, Nishi Shah, Noah Kornblum, Kira Gritsman, Eric Feldman, Amit Verma, Ira Braunschweig, Yogen Saunthararajah, Mendel Goldfinger
Research output: Contribution to journal › Article › peer-review